BlueLinx (BXC) Q1 2025 earnings summary

Executive summary

• Q1 2025 net sales were $709 million, down 2.3% year-over-year, with specialty product sales declining 4.9–5% and structural product sales rising 3–3.3%.

• Net income was $2.8 million ($0.33 per share), with adjusted net income of $2.3 million ($0.27 per share); adjusted EBITDA was $19.6 million (2.8% margin), down 49.6% year-over-year.

• Gross margin declined to 15.7% from 17.6% year-over-year, reflecting margin compression in both specialty and structural products.

• Free cash flow was negative $40 million, with operating cash flow negative $34 million, mainly due to lower net income and working capital changes.

• $15 million in share repurchases completed during Q1; $31 million remains authorized.

Financial highlights

• Gross profit was $111 million, down 13% year-over-year; gross margin 15.7% (down 190 bps).

• Specialty products contributed 68–70% of net sales and 80–81% of gross profit; structural products made up 32% of sales and 19% of gross profit.

• SG&A expenses increased to $94 million, mainly due to technology initiatives and higher logistics costs.

• Adjusted EBITDA margin was 2.8%, down from 5.3% year-over-year; excluding duty-related items, margin was 2.4%.

• Cash and cash equivalents at quarter-end were $449 million; available liquidity $795 million including undrawn revolver.

Outlook and guidance

• Early Q2 2025: specialty product gross margin in the 17–18% range, structural product gross margin 9–10%, with improved daily sales volumes.

• Management expects long-term positive trends in housing and repair/remodel markets, but near-term outlook remains uncertain due to tariffs, high mortgage rates, and economic uncertainty.

• Primary liquidity sources are expected to be sufficient for ongoing requirements for at least the next 12 months.

• Strategic focus remains on growing higher-margin specialty products and expanding value-added services.